http://www.xencor.com Proteins By Design Fri, 26 Apr 2013 17:15:00 +0000 en-US hourly 1 http://wordpress.org/?v=3.5.1 http://www.xencor.com/2013/04/monoclonal-antibody-with-xencors-high-adcc-fc-technology-enters-phase-2-study-in-b-cell-acute-lymphoblastic-leukemia/ http://www.xencor.com/2013/04/monoclonal-antibody-with-xencors-high-adcc-fc-technology-enters-phase-2-study-in-b-cell-acute-lymphoblastic-leukemia/#comments Fri, 26 Apr 2013 17:15:00 +0000 xencor http://www.xencor.com/?p=2091 …]]> http://www.xencor.com/2013/04/monoclonal-antibody-with-xencors-high-adcc-fc-technology-enters-phase-2-study-in-b-cell-acute-lymphoblastic-leukemia/feed/ 0 http://www.xencor.com/2013/04/xencor-licenses-xtend-therapeutic-protein-half-life-extension-technology-to-csl/ http://www.xencor.com/2013/04/xencor-licenses-xtend-therapeutic-protein-half-life-extension-technology-to-csl/#comments Tue, 16 Apr 2013 17:18:22 +0000 xencor http://www.xencor.com/?p=2084 …]]> http://www.xencor.com/2013/04/xencor-licenses-xtend-therapeutic-protein-half-life-extension-technology-to-csl/feed/ 0 http://www.xencor.com/2013/03/04-29-13-05-03-13/ http://www.xencor.com/2013/03/04-29-13-05-03-13/#comments Mon, 25 Mar 2013 22:01:28 +0000 xencor http://www.xencor.com/?p=2078 http://www.xencor.com/2013/03/04-29-13-05-03-13/feed/ 0 http://www.xencor.com/2013/03/matthew-j-bernett-seung-y-chu-irene-leung-gregory-l-moore-sung-hyung-lee-erik-pong-hsing-chen-sheryl-phung-umesh-s-muchhal-holly-m-horton-greg-a-lazar-john-r-desjarlais-david-e-szy/ http://www.xencor.com/2013/03/matthew-j-bernett-seung-y-chu-irene-leung-gregory-l-moore-sung-hyung-lee-erik-pong-hsing-chen-sheryl-phung-umesh-s-muchhal-holly-m-horton-greg-a-lazar-john-r-desjarlais-david-e-szy/#comments Mon, 25 Mar 2013 20:13:18 +0000 xencor http://www.xencor.com/?p=2075 …]]> http://www.xencor.com/2013/03/matthew-j-bernett-seung-y-chu-irene-leung-gregory-l-moore-sung-hyung-lee-erik-pong-hsing-chen-sheryl-phung-umesh-s-muchhal-holly-m-horton-greg-a-lazar-john-r-desjarlais-david-e-szy/feed/ 0 http://www.xencor.com/2013/02/02-26-13-02-27-13/ http://www.xencor.com/2013/02/02-26-13-02-27-13/#comments Tue, 26 Feb 2013 14:00:39 +0000 xencor http://www.xencor.com/?p=2046 http://www.xencor.com/2013/02/02-26-13-02-27-13/feed/ 0 http://www.xencor.com/2013/02/xencor-initiates-phase-1b2a-trial-of-xmabr5871-for-autoimmune-disease/ http://www.xencor.com/2013/02/xencor-initiates-phase-1b2a-trial-of-xmabr5871-for-autoimmune-disease/#comments Wed, 13 Feb 2013 17:33:34 +0000 xencor http://www.xencor.com/?p=2060 …]]> http://www.xencor.com/2013/02/xencor-initiates-phase-1b2a-trial-of-xmabr5871-for-autoimmune-disease/feed/ 0 http://www.xencor.com/2013/01/xencor-receives-milestone-payment-for-xtend-antibody/ http://www.xencor.com/2013/01/xencor-receives-milestone-payment-for-xtend-antibody/#comments Thu, 17 Jan 2013 18:42:47 +0000 xencor http://www.xencor.com/?p=2043 …]]> http://www.xencor.com/2013/01/xencor-receives-milestone-payment-for-xtend-antibody/feed/ 0 http://www.xencor.com/2012/11/11-09-12-11-14-12/ http://www.xencor.com/2012/11/11-09-12-11-14-12/#comments Thu, 08 Nov 2012 00:14:53 +0000 xencor http://www.xencor.com/?p=2030 http://www.xencor.com/2012/11/11-09-12-11-14-12/feed/ 0 http://www.xencor.com/2012/11/morphosys-and-xencor-report-clinical-data-for-mor208xmab5574-phase-12a-trial-in-cllsll-patients-met-primary-and-secondary-objectives/ http://www.xencor.com/2012/11/morphosys-and-xencor-report-clinical-data-for-mor208xmab5574-phase-12a-trial-in-cllsll-patients-met-primary-and-secondary-objectives/#comments Mon, 05 Nov 2012 19:58:06 +0000 xencor http://www.xencor.com/?p=2020 …]]> http://www.xencor.com/2012/11/morphosys-and-xencor-report-clinical-data-for-mor208xmab5574-phase-12a-trial-in-cllsll-patients-met-primary-and-secondary-objectives/feed/ 0 http://www.xencor.com/2012/09/fiercebiotech-10-next-gen-biologics-platforms/ http://www.xencor.com/2012/09/fiercebiotech-10-next-gen-biologics-platforms/#comments Fri, 28 Sep 2012 16:12:39 +0000 xencor http://www.xencor.com/?p=2012 http://www.xencor.com/2012/09/fiercebiotech-10-next-gen-biologics-platforms/feed/ 0